{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:32:31Z","timestamp":1790904751594,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010783","name":"Slovensk\u00e1 Akad\u00e9mia Vied","doi-asserted-by":"publisher","award":["VEGA 1\/0286\/22"],"award-info":[{"award-number":["VEGA 1\/0286\/22"]}],"id":[{"id":"10.13039\/100010783","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003193","name":"Ministerstvo \u0161kolstva, vedy, v\u00fdskumu a \u0161portu Slovenskej republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-16-0021"],"award-info":[{"award-number":["APVV-16-0021"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Probes"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.mcp.2022.101862","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T01:02:55Z","timestamp":1663981375000},"page":"101862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Circulating metabolites in the early stage of breast cancer were not related to cancer stage or subtypes but associated with ki67 level. Promising statistical discrimination from controls"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1357-9368","authenticated-orcid":false,"given":"Eva","family":"Baranovicova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Racay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavol","family":"Zubor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Smolar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kudelova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Halasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Dvorska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Dankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mcp.2022.101862_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/10409238.2019.1611733","article-title":"Determinants of nutrient limitation in cancer","volume":"54","author":"Sullivan","year":"2019","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"3\u20134","key":"10.1016\/j.mcp.2022.101862_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000430844","article-title":"Metabolomics biomarkers for breast cancer","volume":"82","author":"G\u00fcnther","year":"2015","journal-title":"Pathobiol. J. Immunopathol. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.mcp.2022.101862_bib3","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/iub.2149","volume":"71","author":"Baranovi\u010dov\u00e1","year":"2019","journal-title":"IUBMB Life"},{"issue":"4","key":"10.1016\/j.mcp.2022.101862_bib4","doi-asserted-by":"crossref","first-page":"852","DOI":"10.4149\/neo_2021_210103N3","article-title":"Metabolomic profiling of blood plasma of patients with lung cancer and malignant tumors with metastasis in the lungs showed similar features and promising statistical discrimination against controls","volume":"68","author":"Sarlinova","year":"2021","journal-title":"Neoplasma"},{"key":"10.1016\/j.mcp.2022.101862_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpba.2018.07.024","article-title":"Metabolic fingerprinting in breast cancer stages through 1H NMR spectroscopy-based metabolomic analysis of plasma","volume":"160","author":"Suman","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.mcp.2022.101862_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169330","article-title":"1H NMR metabolomics reveals association of high expression of Inositol 1, 4, 5 trisphosphate receptor and metabolites in breast cancer patients","volume":"12","author":"Singh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.mcp.2022.101862_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.708052","article-title":"NMR-based metabolomics analysis predicts response to neoadjuvant chemotherapy for triple-negative breast cancer","author":"He","year":"2021","journal-title":"Front. Mol. Biosci"},{"issue":"1","key":"10.1016\/j.mcp.2022.101862_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5306\/wjco.v7.i1.122","article-title":"Targeting metabolism in breast cancer: how far we can go?","volume":"7","author":"Long","year":"2016","journal-title":"World J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.mcp.2022.101862_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/onc.2009.358","article-title":"Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer","volume":"29","author":"DeBerardinis","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.mcp.2022.101862_bib10","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.2147\/OTT.S215628","article-title":"Metabolomics: a promising diagnostic and therapeutic implement for breast cancer","volume":"12","author":"Chen","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.mcp.2022.101862_bib11","series-title":"Novel Biomarkers in the Continuum of Breast Cancer [Internet]","first-page":"217","article-title":"Metabolomics in breast cancer: current status and perspectives","author":"Hart","year":"2016"},{"issue":"1","key":"10.1016\/j.mcp.2022.101862_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41389-022-00393-8","article-title":"Breast cancer in the era of integrating \u201cOmics\u201d approaches","volume":"11","author":"Rossi","year":"2022","journal-title":"Oncogenesis"},{"issue":"2","key":"10.1016\/j.mcp.2022.101862_bib13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/ije\/dyx271","article-title":"NMR metabolomic signatures reveal predictive plasma metabolites associated with long-term risk of developing breast cancer","volume":"47","author":"L\u00e9cuyer","year":"2018","journal-title":"Int. J. Epidemiol."},{"issue":"8","key":"10.1016\/j.mcp.2022.101862_bib14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4161\/cc.10.8.15330","article-title":"Ketones and lactate increase cancer cell \u201cstemness,\u201d driving recurrence, metastasis and poor clinical outcome in breast cancer","volume":"10","author":"Martinez-Outschoorn","year":"2011","journal-title":"Cell Cycle"},{"issue":"10","key":"10.1016\/j.mcp.2022.101862_bib15","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1158\/0008-5472.CAN-05-3963","article-title":"Doxorubicin plus interleukin-2 chemoimmunotherapy against breast cancer in mice","volume":"66","author":"Ewens","year":"2006","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.mcp.2022.101862_bib16","first-page":"333","article-title":"Metabolomics in cancer research and emerging applications in clinical oncology","volume":"71","author":"Schmidt","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.mcp.2022.101862_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpba.2018.07.024","article-title":"Metabolic fingerprinting in breast cancer stages through 1H NMR spectroscopy-based metabolomic analysis of plasma","volume":"160","author":"Suman","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.mcp.2022.101862_bib18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1021\/ac503651e","article-title":"Expanding the limits of human blood metabolite quantitation using NMR spectroscopy","volume":"87","author":"Nagana Gowda","year":"2015","journal-title":"Anal. Chem."},{"issue":"D1","key":"10.1016\/j.mcp.2022.101862_bib19","doi-asserted-by":"crossref","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","article-title":"HMDB 5.0: the human metabolome database for 2022","volume":"50","author":"Wishart","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcp.2022.101862_bib20","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1002\/mrc.1121","article-title":"Use of H-1 NMR-determined diffusion coefficients to characterize lipoprotein fractions in human blood plasma","volume":"40","author":"Liu","year":"2002","journal-title":"Magn. Reson. Chem."},{"issue":"W1","key":"10.1016\/j.mcp.2022.101862_bib21","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"23","key":"10.1016\/j.mcp.2022.101862_bib22","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1007\/s00216-018-1217-1","article-title":"Overoptimism in cross-validation when using partial least squares-discriminant analysis for omics data: a systematic study","volume":"410","author":"Rodr\u00edguez-P\u00e9rez","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.mcp.2022.101862_bib23","unstructured":"Guyon I, Elisseeff A. An Introduction to Variable and Feature Selection. :26."},{"issue":"1","key":"10.1016\/j.mcp.2022.101862_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12864-019-6413-7","article-title":"The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation","volume":"21","author":"Chicco","year":"2020","journal-title":"BMC Genom."},{"key":"10.1016\/j.mcp.2022.101862_bib25","article-title":"Hyperglycemia and chemoresistance in breast cancer: from cellular mechanisms to treatment response","volume":"11","author":"Qiu","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.mcp.2022.101862_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40170-016-0147-7","article-title":"Pre-diagnosis blood glucose and prognosis in women with breast cancer","volume":"4","author":"Monzavi-Karbassi","year":"2016","journal-title":"Cancer Metabol."},{"issue":"8","key":"10.1016\/j.mcp.2022.101862_bib27","doi-asserted-by":"crossref","first-page":"E2252","DOI":"10.3390\/cancers12082252","article-title":"Targeting glucose metabolism to overcome resistance to anticancer chemotherapy in breast cancer","volume":"12","author":"Varghese","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.mcp.2022.101862_bib28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s13167-020-00217-y","article-title":"Flavonoids against the Warburg phenotype\u2014concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism","volume":"11","author":"Samec","year":"2020","journal-title":"EPMA J."},{"issue":"4","key":"10.1016\/j.mcp.2022.101862_bib29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.semnephrol.2019.04.007","article-title":"The warburg effect, lactate, and nearly a century of trying to cure cancer","volume":"39","author":"Spencer","year":"2019","journal-title":"Semin. Nephrol."},{"issue":"7678","key":"10.1016\/j.mcp.2022.101862_bib30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature24057","article-title":"Glucose feeds the TCA cycle via circulating lactate","volume":"551","author":"Hui","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mcp.2022.101862_bib31","first-page":"64","article-title":"Branched-chain amino acid metabolism in cancer","volume":"21","author":"Ananieva","year":"2018","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"3","key":"10.1016\/j.mcp.2022.101862_bib32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3390\/cancers14030585","article-title":"Expression of 3-methylcrotonyl-CoA carboxylase in brain tumors and capability to catabolize leucine by human neural cancer cells","volume":"14","author":"Gond\u00e1\u0161","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.mcp.2022.101862_bib33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbrc.2017.02.101","article-title":"Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function","volume":"486","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6009","key":"10.1016\/j.mcp.2022.101862_bib34","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1126\/science.1193497","article-title":"Autophagy and metabolism","volume":"330","author":"Rabinowitz","year":"2010","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.mcp.2022.101862_bib35","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2890","article-title":"Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B","volume":"18","author":"Sun","year":"2012","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.mcp.2022.101862_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.mcp.2022.101862_bib37","article-title":"Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation","volume":"6","author":"Bartmann","year":"2018","journal-title":"Cancer Metabol."},{"issue":"23_Supplement","key":"10.1016\/j.mcp.2022.101862_bib38","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.EPIMETAB20-PO-057","article-title":"Abstract PO-057: breast cancer cell metabolism: effect of beta-hydroxybutyrate on glucose deprived breast cancer cells","volume":"80","author":"Maldonado","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcp.2022.101862_bib39","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40170-017-0166-z","article-title":"The action of \u03b2-hydroxybutyrate on the growth, metabolism and global histone H3 acetylation of spontaneous mouse mammary tumours: evidence of a \u03b2-hydroxybutyrate paradox","volume":"5","author":"Rodrigues","year":"2017","journal-title":"Cancer Metabol."},{"key":"10.1016\/j.mcp.2022.101862_bib40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molmet.2019.06.026","article-title":"Ketogenic diet in the treatment of cancer \u2013 where do we stand?","volume":"33","author":"Weber","year":"2020","journal-title":"Mol. Metabol."},{"issue":"8","key":"10.1016\/j.mcp.2022.101862_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-017-0991-5","article-title":"Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation","volume":"34","author":"Klement","year":"2017","journal-title":"Med. Oncol."},{"key":"10.1016\/j.mcp.2022.101862_bib42","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cbpa.2015.10.030","article-title":"Metabolic control of methylation and acetylation","volume":"30","author":"Su","year":"2016","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"6116","key":"10.1016\/j.mcp.2022.101862_bib43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1227166","article-title":"Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mcp.2022.101862_bib44","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3390\/biom11030402","article-title":"3-Hydroxybutyrate as a metabolite and a signal molecule regulating processes of living organisms","volume":"11","author":"Mierziak","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.mcp.2022.101862_bib45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tem.2013.09.002","article-title":"Ketone bodies as signaling metabolites","volume":"25","author":"Newman","year":"2014","journal-title":"Trends Endocrinol. Metab. TEM"},{"key":"10.1016\/j.mcp.2022.101862_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.603552","article-title":"Perspectives on the role of histone modification in breast cancer progression and the advanced technological tools to study epigenetic determinants of metastasis","volume":"11","author":"Zhuang","year":"2020","journal-title":"Front. Genet."},{"issue":"6","key":"10.1016\/j.mcp.2022.101862_bib47","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.metabol.2009.02.011","article-title":"Metabolism of histamine in tissues of primary ductal breast cancer","volume":"58","author":"von Mach-Szczypi\u0144ski","year":"2009","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.mcp.2022.101862_bib48","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1570-0232(02)00541-X","article-title":"Determination of histamine in the whole blood of colon cancer patients","volume":"780","author":"Previati","year":"2002","journal-title":"J. Chromatogr. B"},{"issue":"3","key":"10.1016\/j.mcp.2022.101862_bib49","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5306\/wjco.v5.i3.412","article-title":"Biological subtypes of breast cancer: prognostic and therapeutic implications","volume":"5","author":"Yersal","year":"2014","journal-title":"World J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.mcp.2022.101862_bib50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/cancers13010147","article-title":"Human plasma metabolomics for biomarker discovery: targeting the molecular subtypes in breast cancer","volume":"13","author":"D\u00edaz-Beltr\u00e1n","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.mcp.2022.101862_bib51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.mcp.2022.101862_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4062\/biomolther.2017.178","article-title":"Targeting glutamine metabolism for cancer treatment","volume":"26","author":"Choi","year":"2018","journal-title":"Biomol. Ther."},{"issue":"1","key":"10.1016\/j.mcp.2022.101862_bib53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metabol."},{"issue":"12","key":"10.1016\/j.mcp.2022.101862_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225129","article-title":"Plasma metabolites as possible biomarkers for diagnosis of breast cancer","volume":"14","author":"Park","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.mcp.2022.101862_bib55","doi-asserted-by":"crossref","first-page":"19522","DOI":"10.18632\/oncotarget.14521","article-title":"A plasma metabolomic signature discloses human breast cancer","volume":"8","author":"Jov\u00e9","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.mcp.2022.101862_bib56","first-page":"280","article-title":"Translational biomarker discovery in clinical metabolomics: an introductory tutorial","volume":"9","author":"Xia","year":"2013","journal-title":"Metabol. Off. J. Metabol. Soc."}],"container-title":["Molecular and Cellular Probes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850822000731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850822000731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:18:08Z","timestamp":1760192288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890850822000731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":56,"alternative-id":["S0890850822000731"],"URL":"https:\/\/doi.org\/10.1016\/j.mcp.2022.101862","relation":{},"ISSN":["0890-8508"],"issn-type":[{"value":"0890-8508","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating metabolites in the early stage of breast cancer were not related to cancer stage or subtypes but associated with ki67 level. Promising statistical discrimination from controls","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Probes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcp.2022.101862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101862"}}